IL‐23/IL‐17 immune axis mediates the imiquimod‐induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF‐κB pathway in macrophages and keratinocytes

IL‐23/IL‐17 immune axis mediates the imiquimod‐induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF‐κB pathway in macrophages and keratinocytes

Abstract The interleukin‐23 (IL‐23)/IL‐17 immune axis has been linked to the pathology of psoriasis, but how this axis contributes to skin inflammation in this disease remains unclear. We measured inflammatory cytokines associated with the IL‐23/IL‐17 immune axis in the serum of patients with psoria...

Full description

Bibliographic Details
Main Authors:	Wen‐Cheng Chen, Chang‐Hui Wen, Meng Wang, Zi‐Dan Xiao, Zhong‐Zhao Zhang, Chun‐Lan Wu, Ran Wu
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	Kaohsiung Journal of Medical Sciences
Subjects:	interleukin 17 interleukin 23 NF‐κB psoriasis skin inflammation
Online Access:	https://doi.org/10.1002/kjm2.12683

Similar Items

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
by: Marie-Astrid Boutet, et al.
Published: (2018-02-01)

IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis
by: Yuzhu Hou, et al.
Published: (2018-03-01)

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
by: Haugh IM, et al.
Published: (2018-11-01)

Canonical NF-κB p65, but Not p105, Contributes to IL-1β-Induced IL-8 Expression in Cardiac Fibroblasts
by: Masashi Mizuno, et al.
Published: (2022-04-01)

YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-κB
by: Gisela Schimmack, et al.
Published: (2017-02-01)

NHWD-1062 ameliorates inflammation and proliferation by the RIPK1/NF-κB/TLR1 axis in Psoriatic Keratinocytes
by: Yiyan Guo, et al.
Published: (2023-06-01)

Perturbation of the Actin Cytoskeleton in Human Hepatoma Cells Influences Interleukin-6 (IL-6) Signaling, but Not Soluble IL-6 Receptor Generation or NF-κB Activation
by: Elizabeta Georgieva, et al.
Published: (2021-07-01)

Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors
by: Yu-Huei Huang, et al.
Published: (2023-02-01)

Anti-Psoriatic Effects and IL-22 Targeting Mechanism of Indirubin by Suppressing Keratinocyte Inflammation and Proliferation
by: Ly Thi Huong Nguyen, et al.
Published: (2021-12-01)

Nobiletin Inhibits IL-1β-Induced Inflammation in Chondrocytes via Suppression of NF-κB Signaling and Attenuates Osteoarthritis in Mice
by: Zeng Lin, et al.
Published: (2019-05-01)

Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
by: Elisabetta Bianchi, et al.
Published: (2021-09-01)

Salvianolic Acid B in Microemulsion Formulation Provided Sufficient Hydration for Dry Skin and Ameliorated the Severity of Imiquimod-induced Psoriasis-like Dermatitis in Mice
by: Jiun-Wen Guo, et al.
Published: (2020-05-01)

Levels of IL-23/IL-17 Axis in Plasma and Gingival Tissue of Periodontitis Patients According to the New Classification
by: Ruth Rodríguez-Montaño, et al.
Published: (2022-08-01)

Psoriasis-Associated Inflammatory Conditions Induce IL-23 mRNA Expression in Normal Human Epidermal Keratinocytes
by: Evelyn Kelemen, et al.
Published: (2022-01-01)

Expressions of IL-17, IL-21 and IL-23 in the serum of allergic rhinitis patients
by: Huang Xuekun, et al.
Published: (2011-01-01)

Multifaceted Analysis of IL-23A- and/or EBI3-Including Cytokines Produced by Psoriatic Keratinocytes
by: Kota Tachibana, et al.
Published: (2021-11-01)

New Findings on Autoimmune Etiology of Idiopathic Granulomatous Mastitis: Serum IL-17, IL-22 and IL-23 Levels of Patients
by: Mehmet Saydam, et al.
Published: (2021-08-01)

Punicalagin Alleviates Psoriasis by Inhibiting NF-κB-Mediated IL-1β Transcription and Caspase-1-Regulated IL-1β Secretion
by: Lipeng Tang, et al.
Published: (2022-01-01)

A wild rice-derived peptide R14 ameliorates monosodium urate crystals-induced IL-1β secretion through inhibition of NF-κB signaling and NLRP3 inflammasome activation
by: Supattra Charoenwutthikun, et al.
Published: (2023-05-01)

Pro‐inflammatory cytokine IL‐6 regulates LMO4 expression in psoriatic keratinocytes via AKT/STAT3 pathway
by: Zhenzhen Tu, et al.
Published: (2023-12-01)

IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer
by: Ali Khodadadi, et al.
Published: (2014-07-01)

Effectiveness of IL-23 Inhibitor Guselkumab in Real-World Chinese Patients with Psoriasis During a 20-Week Period
by: Chan Y, et al.
Published: (2021-06-01)

8-Methoxypsoralen Plus Ultraviolet A Reduces the Psoriatic Response to Imiquimod in a Murine Model
by: Nitesh Shirsath, et al.
Published: (2018-03-01)

Genetic Variants of the NF-κB Pathway: Unraveling the Genetic Architecture of Psoriatic Disease
by: Rubén Queiro, et al.
Published: (2021-11-01)

IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential
by: Marie-Astrid Boutet, et al.
Published: (2019-03-01)

Imbalance of expression levels of IL-36γ and IL-38 is possibly associated with the severity of inflammation in psoriasis vulgaris
by: Jiao ZHANG, et al.
Published: (2023-02-01)

Effects of Thai Medicinal Herb Extracts with Anti-Psoriatic Activity on the Expression on NF-κB Signaling Biomarkers in HaCaT Keratinocytes
by: Tewin Tencomnao, et al.
Published: (2011-05-01)

Plasma cytokine response, lipid peroxidation and NF-κB activation in skeletal muscle following maximum progressive swimming
by: L.S. Cleto, et al.
Published: (2011-06-01)

The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
by: Hiroyuki Tsukazaki, et al.
Published: (2020-09-01)

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study
by: Gianluca Avallone, et al.
Published: (2023-02-01)

Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
by: Gloria Pastor-Fernández, et al.
Published: (2020-09-01)

Correlation analysis between IL-35, IL-36γ, CCL27 and psoriasis vulgaris
by: Jiao Chen, et al.
Published: (2021-08-01)

NIL10: A New IL10-Receptor Binding Nanoparticle That Induces Cardiac Protection in Mice and Pigs Subjected to Acute Myocardial Infarction through STAT3/NF-κB Activation
by: Laura Tesoro, et al.
Published: (2022-09-01)

Serum Levels of Il-12 and Il-23 in Breast Cancer Patients Infected with Toxoplasma gondii: A Case-Control Study
by: Maha Mustafa ASSIM, et al.
Published: (2020-12-01)

IL-23 Gene and Protein Expression in Childhood Asthma
by: Soheila Alyasin, et al.
Published: (2017-03-01)

Investigation of the Relationship Between IL-1Ra VNTR Variants and Psoriasis
by: Aysegul Basak Akadam Teker, et al.
Published: (2021-06-01)

VA inhibits LPS-induced oxidative stress via modulating Nrf2/NF-κB-signalling pathways in bovine mammary epithelial cells
by: Huiyu Shi, et al.
Published: (2019-01-01)

Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
by: Guillermo Sánchez-Rodríguez, et al.
Published: (2023-06-01)

Drug survival of biologic agents in patients with psoriatic arthritis from a medical center in southern Taiwan
by: Sebastian Yu, et al.
Published: (2022-01-01)

Prospects for the use of monoclonal antibodies to interleukin 23 Gusеlkumab in psoriatic arthritis: New data
by: E. L. Nasonov, et al.
Published: (2022-03-01)